Listen "ALSUntangled Series: Ep. 10 - Lunasin"
Episode Synopsis
Lunasin, a peptide first isolated from soybeans, is associated with an “ALS reversal.” We explain why we once had great hope for this as an ALS treatment. We then review the results from a recently-completed, year-long clinical trial of Lunasin in 50 people with ALS. Unfortunately, no one in this trial had an ALS reversal or even any detectable slowing of their progression, and there were unexpected GI side effects including constipation severe enough to warrant hospitalization.
More episodes of the podcast CReATe Podcast
ALS Untangled Series Ep. 62 - Ashwagandha
20/10/2025
ALS Untangled Series Ep. 61 - Zinc
09/09/2025
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS
01/05/2025
ALS Untangled Series Ep. 60 - Nuedexta
04/12/2024
ALS Untangled Series Ep. 59 - Lions Mane
04/11/2024
ALS Untangled Series Ep. 58 - Insulin
01/10/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.